CHA new cancer treatment for pancreatic cancer has achieved significant success in the United States by doubling survival times. However, in Switzerland, patients are unable to access this medication due to President Trump's price guarantee policy, which limits market availability.
Bias read (Progressive): The article frames the issue as a consequence of U.S. political decisions affecting Swiss healthcare access. It highlights the negative impact of Trump's policies on patient care, using terms like 'verhindert' (prevents) and focusing on the disparity between U.S. and Swiss outcomes, suggesting a pro
